Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Gene therapy for cancer through adenovirus vector‑mediated expression of the Ad5 early region gene 1A based on loss of IGF2 imprinting.

Pan Y, He B, Lirong Z, Nie Z, Chen L, Gu L, Hoffman AR, Wang S, Hu J.

Oncol Rep. 2013 Oct;30(4):1814-22. doi: 10.3892/or.2013.2646. Epub 2013 Jul 30.

2.

Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system.

Nie ZL, Pan YQ, He BS, Gu L, Chen LP, Li R, Xu YQ, Gao TY, Song GQ, Hoffman AR, Wang SK, Hu JF.

Mol Cancer. 2012 Nov 21;11:86. doi: 10.1186/1476-4598-11-86.

3.

[Effect of recombinant adenovirus Ad-DT-A in targeted therapy for malignant cancer cell lines with loss of IGF2 imprinting].

Pan YQ, He BS, Zhu C, Qu LL, Xu XF, Wang SK.

Zhonghua Zhong Liu Za Zhi. 2011 Nov;33(11):816-21. Chinese.

PMID:
22335945
4.

Gene therapy for human colorectal cancer cell lines with recombinant adenovirus 5 based on loss of the insulin-like growth factor 2 imprinting.

Sun H, Pan Y, He B, Deng Q, Li R, Xu Y, Chen J, Gao T, Ying H, Wang F, Liu X, Wang S.

Int J Oncol. 2015 Apr;46(4):1759-67. doi: 10.3892/ijo.2015.2852. Epub 2015 Jan 26.

PMID:
25625919
5.

Targeted tumor gene therapy based on loss of IGF2 imprinting.

Pan Y, He B, Li T, Zhu C, Zhang L, Wang B, Xu Y, Qu L, Hoffman AR, Wang S, Hu J.

Cancer Biol Ther. 2010 Aug 1;10(3):290-8. Epub 2010 Aug 21.

6.

Gene therapy for colorectal cancer by adenovirus-mediated siRNA targeting CD147 based on loss of the IGF2 imprinting system.

Pan Y, He B, Chen J, Sun H, Deng Q, Wang F, Ying H, Liu X, Lin K, Peng H, Xie H, Wang S.

Int J Oncol. 2015 Nov;47(5):1881-9. doi: 10.3892/ijo.2015.3181. Epub 2015 Sep 23.

PMID:
26397886
7.

Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.

Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, Feinberg AP.

Cancer Res. 2002 Nov 15;62(22):6442-6.

8.

Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.

Zhao X, Liu X, Wang G, Wen X, Zhang X, Hoffman AR, Li W, Hu JF, Cui J.

Oncotarget. 2016 Aug 9;7(32):51349-51364. doi: 10.18632/oncotarget.9784.

9.

Tissue-specific relationship of S-adenosylhomocysteine with allele-specific H19/Igf2 methylation and imprinting in mice with hyperhomocysteinemia.

Glier MB, Ngai YF, Sulistyoningrum DC, Aleliunas RE, Bottiglieri T, Devlin AM.

Epigenetics. 2013 Jan;8(1):44-53. doi: 10.4161/epi.23063. Epub 2012 Dec 5.

10.
11.

Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.

Wang H, Wei F, Li H, Ji X, Li S, Chen X.

Int J Mol Med. 2013 Feb;31(2):377-85. doi: 10.3892/ijmm.2012.1197. Epub 2012 Nov 29.

PMID:
23229955
12.

Loss of imprinting of IGF2 correlates with hypomethylation of the H19 differentially methylated region in the tumor tissue of colorectal cancer patients.

Tian F, Tang Z, Song G, Pan Y, He B, Bao Q, Wang S.

Mol Med Rep. 2012 Jun;5(6):1536-40. doi: 10.3892/mmr.2012.833. Epub 2012 Mar 13.

PMID:
22427002
13.

H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway.

Gao T, He B, Pan Y, Gu L, Chen L, Nie Z, Xu Y, Li R, Wang S.

Clin Transl Oncol. 2014 Apr;16(4):410-7. doi: 10.1007/s12094-013-1098-x. Epub 2013 Aug 13.

PMID:
23943562
14.

Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells.

Vu TH, Nguyen AH, Hoffman AR.

Hum Mol Genet. 2010 Mar 1;19(5):901-19. doi: 10.1093/hmg/ddp558. Epub 2009 Dec 16.

15.

Analysis of imprinted IGF2/H19 gene methylation and expression in normal fertilized and parthenogenetic embryonic stem cells of pigs.

Uh KJ, Park CH, Choi KH, Park JK, Jeong YW, Roh S, Hyun SH, Shin T, Lee CK, Hwang WS.

Anim Reprod Sci. 2014 Jun 10;147(1-2):47-55. doi: 10.1016/j.anireprosci.2014.03.020. Epub 2014 Apr 12.

PMID:
24794444
16.

Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer.

Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, de La Chapelle A.

Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):591-6. Epub 2000 Dec 19.

17.

The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications.

Vennin C, Spruyt N, Robin YM, Chassat T, Le Bourhis X, Adriaenssens E.

Cancer Lett. 2017 Jan 28;385:198-206. doi: 10.1016/j.canlet.2016.10.023. Epub 2016 Oct 22.

PMID:
27780718
18.

Promoter histone H3K27 methylation in the control of IGF2 imprinting in human tumor cell lines.

Li T, Chen H, Li W, Cui J, Wang G, Hu X, Hoffman AR, Hu J.

Hum Mol Genet. 2014 Jan 1;23(1):117-28. doi: 10.1093/hmg/ddt405. Epub 2013 Aug 19.

19.

Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.

Cheng YW, Idrees K, Shattock R, Khan SA, Zeng Z, Brennan CW, Paty P, Barany F.

Int J Cancer. 2010 Aug 1;127(3):568-77. doi: 10.1002/ijc.25086.

20.

Relationship of porcine IGF2 imprinting status to DNA methylation at the H19 DMD and the IGF2 DMRs 1 and 2.

Braunschweig MH, Owczarek-Lipska M, Stahlberger-Saitbekova N.

BMC Genet. 2011 May 17;12:47. doi: 10.1186/1471-2156-12-47.

Supplemental Content

Support Center